Skip to main content

Advertisement

SpringerLink
Log in

Dual Effect of IL-6 -174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Inflammation plays an important role in the pathogenesis of atherosclerosis and coronary syndromes; moreover, various lines of evidence suggest that genetic factors do contribute to the risk of coronary artery disease (CAD). The proinflammatory cytokine IL-6 is a central mediator of inflammation associated with CAD. The present study is aimed to investigate the association of single nucleotide polymorphism in the promoter region of the IL-6 gene (-174 G > C) and methylation with the susceptibility of CAD. Genotyping of IL-6 -174 G/C polymorphism was performed by PCR–RFLP. Methylation-specific PCR method was used to study the IL-6 gene promoter methylation. Analysis of 470 subjects (265 CAD patients and 205 controls) showed association of the -174 G/C variant with the CAD risk in dominant model (OR 1.58, 95% CI, 1.024–2.23, P = 0.04). Further, the analysis of the distribution of genotypes and alleles of -174 G > C polymorphism according to clinical features of CAD, revealed significant association of genotype and allele (OR 1.86, 95% CI 1.18–2.84 P = 0.01, and OR 1.71, 95% CI 1.09–2.23 P = 0.02 respectively) with diabetes, and we found no association with hypertension (OR 0.95, 95% CI 0.57–1.59, P = 0.8). We also analyzed the methylation status of IL-6 promoter region between cases and controls showed significant hypo methylation in CAD subjects (OR 2.36, 95% CI 1.51–4.259, P = 0.006). Additionally, GC, CC genotypes and C allele carriers show hypomethylation in CAD cases compared to controls (54.58 vs. 76.85%, 29.83 vs. 40% respectively). In conclusion, the promoter polymorphism -174 G/C is associated with CAD risk and further carriers of ‘C’ allele at -174 locus showed significant hypo methylation which could contribute to increased risk of CAD. The present study highlights the association of allele and genotypes with differential DNA methylation of CpG islands in the IL-6 promoter region which may affect IL-6 gene regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;13:256.

    Article  Google Scholar 

  2. Kreatsoulas C, Sloane D, Pogue J, Velianou JL, Anand SS. Referrals in acute coronary events for CARdiac catheterization The RACE CAR trial. Can J Cardiol. 2010;8:e290–6.

    Article  Google Scholar 

  3. Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India. Current epidemiology and future directions. Circulation. 2016;16:1605–20.

    Article  Google Scholar 

  4. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J. 1998;19:53–61.

    Google Scholar 

  5. Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016;82:307–15.

    Article  PubMed  Google Scholar 

  6. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041–6.

    Article  CAS  PubMed  Google Scholar 

  7. Paoletti R, Gotto AM Jr, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004;109:20–6.

    Article  Google Scholar 

  8. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468–9.

    Article  CAS  Google Scholar 

  9. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med (Berl). 2001;79:300–5.

    Article  CAS  Google Scholar 

  10. Hojo Y, Ikeda U, Takahashi M, Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis. 2002;161:403–8.

    Article  CAS  PubMed  Google Scholar 

  11. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001;88:10–5.

    Article  Google Scholar 

  12. Loppnow H, Werdan K, Buerke M. Vascular cells contribute to atherosclerosis by cytokineandinnate-immunity-related inflammatory mechanisms. Innate Immun. 2008;14:63–87.

    Article  CAS  PubMed  Google Scholar 

  13. Fernandes MT, Fernandes KB, Marquez AS, Cólus IM. Association of interleukin-6 gene polymorphism (rs1800796) with severity and functional status of osteoarthritis in elderly individuals. Cytokine. 2015;75:316–20.

    Article  CAS  PubMed  Google Scholar 

  14. Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy. 2004;3:35–42.

    Article  CAS  PubMed  Google Scholar 

  15. Li L, Li E, Zhang LH, Jian LG, Liu HP, Wang T. IL-6 174G/C and IL-6-572C/G polymorphisms are associated with increased risk of coronary artery disease. Genet Mol Res. 2015;14(3):8451–7.

    Article  CAS  PubMed  Google Scholar 

  16. Ghazouani L, Ben HadjKhalifa S, Abboud N, Ben Hamda K, Ben Khalfallah A, Brahim N, et al. TNF-alpha -308G > A and IL-6 -174G > C polymorphisms in Tunisian patients with coronary artery disease. ClinBiochem. 2010;43(13–14):1085–9.

    CAS  Google Scholar 

  17. Libra M, Signorelli SS, Bevelacqua Y, Navolanic PM, Bevelacqua V, Polesel J. Analysis of G (174) C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J ClinPathol. 2006;59:211–5.

    CAS  Google Scholar 

  18. Yen RW, Vertino PM, Nelkin BD, Yu JJ, El-Deiry W, Cumaraswamy A, et al. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res. 1992;20:2287–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515–81.

    Article  CAS  PubMed  Google Scholar 

  20. Tso AR, Merino JG, Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke. 2007;38:3070–5.

    Article  CAS  PubMed  Google Scholar 

  21. Kim SK, Chung JH, Kwon OY. Promoter polymorphism (− 174, G/C) of interleukin-6 and arterial thromboembolic events: a meta-analysis. Med Sci Monit. 2016;22:4345–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mann DA. Epigenetics in liver disease. Hepatology. 2014;60:1418–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ozanne SE, Constancia M. Mechanisms of disease. The developmental origins of disease and the role of the epigenotype. Nat. Clin Pract Endocrinol Metab. 2007;3:539–46.

    Article  CAS  PubMed  Google Scholar 

  24. Rodenhister D, Mann M. Epigenetics and human disease: translating basic biology into clinical application. CMAJ. 2006;174:341–8.

    Article  Google Scholar 

  25. Poplutz MK, Wessels I, Rink L, Uciechowski P. Regulation of the interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. Immunobiology. 2014;219:619–26.

    Article  CAS  PubMed  Google Scholar 

  26. Dandrea M, Donadelli M, Costanzo C, Scarpa A, Palmieri M. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res. 2009;37:6681–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhuang J, Peng W, Li H, Wang W, Wei Y, Li W. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease. PLoS ONE. 2012;7(10):e47193.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Tanaka C, Mannami T, Kamide K. Nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in Japanese general population. Hypertens Res. 2005;28:35–41.

    Article  PubMed  Google Scholar 

  29. Koch W, Kastrati A, Bittiger C. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159:137–44.

    Article  CAS  PubMed  Google Scholar 

  30. Sharma S, Rathored J, Ghosh B. Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis. 2010;10:165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–72.

    Article  CAS  PubMed  Google Scholar 

  32. Buraczynska M, Zukowski P, Drop B, Baranowicz-Gaszczyk I, Ksiazek A. Effect of G (− 174) C polymorphism in interleukin-6 gene on cardiovascular disease in type 2 diabetes patients. Cytokine. 2016;79:7–11.

    Article  CAS  PubMed  Google Scholar 

  33. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O’Keefe GE. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock. 2003;20:218–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mao L, Geng GY, Han WJ, Zhao MH, Wu L, Liu HL. Interleukin-6 (IL-6) -174G/C genomic polymorphism contribution to the risk of coronary artery disease in a Chinese population. Genet Mol Res. 2016;15:2.

    Google Scholar 

  35. Wang K, Dong PS, Zhang HF, Li ZJ, Yang XM, Liu H. Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease. Genet Mol Res. 2015;14:3177–83.

    Article  CAS  PubMed  Google Scholar 

  36. Sun GQ, Wu GD, Meng Y, Du B, Li YB. IL-6 gene promoter polymorphisms and risk of coronary artery disease in a Chinese population. Genet Mol Res. 2014;26(13):7718–24.

    Article  CAS  Google Scholar 

  37. Satti HS, Hussain S, Javed Q. Association of interleukin-6 gene promoter polymorphism with coronary artery disease in Pakistani families. Sci World J. 2013;13:538365.

    Google Scholar 

  38. Phulukdaree A, Khan S, Ramkaran P, Govender R, Moodley D, Chuturgoon AA. The interleukin-6 -147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men. Metab Syndr Relat Disord. 2013;11(3):205–9.

    Article  CAS  PubMed  Google Scholar 

  39. Galimudi RK, Spurthi MK, Padala C, Kumar KG, Mudigonda S, Reddy SG, et al. Interleukin 6 (-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives. Inflammation. 2014;37:314–21.

    Article  CAS  PubMed  Google Scholar 

  40. Ghazouani L, Abboud N, Ben HadjKhalifa S, Added F, Ben Khalfallah A, Nsiri B, Mediouni M, Mahjoub T. 174G > C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease. Ann Saudi Med. 2011;31:40–4.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Tong Z, Li Q, Zhang J, Wei Y. Association between interleukin 6 and interleukin 16 gene polymorphisms and coronary heart disease risk in a Chinese population. J Int Med Res. 2013;41:1049–56.

    Article  CAS  PubMed  Google Scholar 

  42. Meraj P, Reza G, Fereshteh A, Kamran G. Association between rs1800795 (− 174 G/C) polymorphism in the promoter of IL6 gene and risk of relapsing-remitting multiple sclerosis (RRMS) in Isfahan population. Open J Genet. 2014;4:407–13.

    Article  CAS  Google Scholar 

  43. Hou H, Wang C, Sun F, Zhao L, Dun A, Sun Z. Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta analysis. Inflamm Res. 2015;64:707–20.

    Article  CAS  PubMed  Google Scholar 

  44. Song Y, Gu HD, He Y, Wang JW. Role of IL-6 polymorphism on the development of cardiovascular events and coronary artery disease in patients receiving hemodialysis. Genet Mol Res. 2015;14:2631–7.

    Article  CAS  PubMed  Google Scholar 

  45. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Caldarera CM, Nanni S, et al. Interleukin-6 gene polymorphism is an age dependent risk factor for myocardial infarction in men. Int J Immunogenet. 2005;32:349–53.

    Article  CAS  PubMed  Google Scholar 

  46. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet. 2012;21:371–83.

    Article  CAS  PubMed  Google Scholar 

  47. Viana MB, Cardoso FP, Diniz MG, Costa FO, da Costa JE, Gomez RS, et al. Methylation pattern of IFN-c and IL-10 genes in periodontal tissues. Immunobiology. 2011;216:936–41.

    Article  CAS  PubMed  Google Scholar 

  48. Bind MA, Lepeule J, Zanobetti A, Gasparrini A, Baccarelli A, Coull BA. Air pollution and gene-specific methylation in the normative aging study: association, effect modification, and mediation analysis. Epigenetics. 2014;9(3):448–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–63.

    Article  CAS  Google Scholar 

  50. Jiang D, Zheng D, Wang L, Huang Y, Liu H, Xu L. Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS ONE. 2013;8(3):e59752.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Zuo HP, Guo YY, Che L, Wu XZ. Hypomethylation of interleukin-6 promoter is associated with the risk of coronary heart disease. Arq Bras Cardiol. 2016;107:131–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A. White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics. 2012;7(6):606–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kirchner H, Nylen C, Laber S, Barres R, Yan J, Krook A. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. Surg Obes Relat Dis. 2014;10(4):671–8.

    Article  PubMed  Google Scholar 

  54. Peluso M, Bollati V, Munnia A, Srivatanakul P, Jedpiyawongse A, Sangrajrang S. DNA methylation differences in exposed workers and nearby residents of the MaTaPhut industrial estate, Rayong, Thailand. Int J Epidemiol. 2012;41(6):1753–60.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Aumueller E, Remely M, Baeck H, Hippe B, Brath H, Haslberger AG. Interleukin-6 CpG methylation and body weight correlate differently in type 2 Diabetes patients compared to obese and lean controls. J Nutrigenet Nutrigenomics. 2015;8(1):26–35.

    Article  CAS  PubMed  Google Scholar 

  56. Jin Y, Wang Q, Wang G, Zhang X, Yan B, Hu W. Common polymorphisms in the interleukin-6 gene and myocardial infarction risk: a meta-analysis. Genet Test Mol Biomarkers. 2014;18(5):330–40.

    Article  CAS  PubMed  Google Scholar 

  57. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol. 2008;79(8):1514–9.

    Article  CAS  PubMed  Google Scholar 

  58. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008;58:2686–93.

    Article  PubMed  Google Scholar 

  59. Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin. 2008;29(1):105–12.

    Article  CAS  PubMed  Google Scholar 

  60. Ishida K, Kobayashi T, Ito S, Komatsu Y, Yokoyama T, Okada M. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol. 2012;83:917–25.

    Article  CAS  PubMed  Google Scholar 

  61. Guarrera S, Fiorito G, Onland-Moret NC, Russo A, Agnoli C, Allione A, et al. Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk. Clin Epigenetics. 2015;7:133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Na YK, Hong HS, Lee WK, Kim YH, Kim DS. Increased methylation of interleukin 6 gene is associated with obesity in Korean women. Mol Cells. 2015;38:452–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Therapeutics, Nizam’s Institute of Medical Sciences (NIMS), Punjagutta, Hyderabad, Telangana, India

    Bobbala Indumathi, Shiva Krishna Katkam & Vijay Kumar Kutala

  2. Department of Cardiology, Nizam’s Institute of Medical Sciences (NIMS), Punjagutta, Hyderabad, Telangana, India

    L. S. R. Krishna

Authors
  1. Bobbala Indumathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiva Krishna Katkam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. S. R. Krishna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vijay Kumar Kutala
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L.K performed clinical investigations and contributed samples. V.K.K provided research material. B.I and S.K.K conducted experiments and analyzed the data. B.I, S.K.K and V.K.K wrote and reviewed the manuscript.

Corresponding author

Correspondence to Vijay Kumar Kutala.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Indumathi, B., Katkam, S.K., Krishna, L.S.R. et al. Dual Effect of IL-6 -174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians. Ind J Clin Biochem 34, 180–187 (2019). https://doi.org/10.1007/s12291-018-0740-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-018-0740-3

Keywords

Search

Navigation